Insulin microinfusors with continuous glucose monitoring, 2nd edition
Original notice title
Italy – Devices and instruments for transfusion and infusion – Microinfusori per insulina integrato o integrabile a sensore per il monitoraggio glicemico in continuo con algoritmo di modulazione dell'insulina basale (sistema a rilascio automatizzato dell'insulina) e correlato materiale di consumo. 2^ edizione
Opportunity Score
Why this score?
Opportunity
50 / 100
Complexity
55 / 100
Risk factors
No selection or award criteria provided; tender cannot be fully evaluated without detailed procurement documents.
Structured data indicates EU-funded, XML notice states no EU funds. This affects contract conditions and compliance.
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Overview
Moderate opportunityKey Facts
- EUR 129.8M estimated value
- Framework procurement
- Supplies contract
- 3 lots
- Duration 48 MONTH
- Supply of automated insulin delivery systems (integrated or integrable with continuous glucose monitoring sensors and basal insulin modulation algorithm) and related consumables.
- Framework agreement with multiple operators (up to 1000), with a framework maximum value equal to the total estimated value.
Show full summary
This tender by Azienda Zero (Italy) is for an open framework agreement for automated insulin delivery systems (microinfusers integrated with continuous glucose monitoring sensors and basal insulin modulation algorithm) and related consumables. The total estimated value is €129,796,146.86 across three lots, each with a 48-month duration. The procurement is conducted via the Sintel e-procurement platform. Key data inconsistencies exist: EU funding status conflicts between structured data (EU-funded) and XML notice (no EU funds). No selection or award criteria are explicitly provided, and no procurement documents beyond the notice have been analyzed.
Risks
No selection or award criteria provided; tender cannot be fully evaluated without detailed procurement documents.
Structured data indicates EU-funded, XML notice states no EU funds. This affects contract conditions and compliance.
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
Technical
- The tender is open and unrestricted in number of operators.
Administrative
- Electronic submission via Sintel platform is mandatory.
- Tenders must be submitted by 5 August 2026, 13:00 (CET?) – note XML notice indicates 15:00; confirm deadline.
Requirements may be incomplete.
Buyer
Lots (3)
LOT-0001
Lotto 1
Lot 1: Automated insulin delivery system and consumables.
EUR 129.8M
Estimated value
Duration
Category
Deadline
Award details
Lotto 1
Value note
Show original TED data
Original TED description
Lotto 1
LOT-0002
Lotto 2
Lot 2: Automated insulin delivery system and consumables.
EUR 129.8M
Estimated value
Duration
Category
Deadline
Award details
Lotto 2
Value note
Show original TED data
Original TED description
Lotto 2
LOT-0003
Lotto 3
Lot 3: Automated insulin delivery system and consumables.
EUR 129.8M
Estimated value
Duration
Category
Deadline
Award details
Lotto 3
Value note
Show original TED data
Original TED description
Lotto 3
Procurement Details
- Publication date
- 23 Jun 2026
- Languages
- Italian
Reference metadata
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 429049-2026
Documents (1)
Similar tenders
Opportunity Score
Why this score?
Opportunity
50 / 100
Complexity
55 / 100
Risk factors
No selection or award criteria provided; tender cannot be fully evaluated without detailed procurement documents.
Structured data indicates EU-funded, XML notice states no EU funds. This affects contract conditions and compliance.
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications